Talis Biomedical Corporation (TLIS)
NASDAQ: TLIS · IEX Real-Time Price · USD
8.98
+0.03 (0.34%)
May 17, 2024, 4:00 PM EDT - Market closed

Talis Biomedical Revenue

Talis Biomedical had revenue of $989.00K in the twelve months ending March 31, 2024, down -65.21% year-over-year. Revenue in the quarter ending March 31, 2024 was $73.00K, a -94.01% decrease year-over-year. In the year 2023, Talis Biomedical had annual revenue of $2.13M, a decrease of -55.65%.

Revenue (ttm)
$989.00K
Revenue Growth
-65.21%
P/S Ratio
16.54
Revenue / Employee
$9,990
Employees
99
Market Cap
16.36M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.13M-2.68M-55.65%
Dec 31, 20224.81M-3.38M-41.27%
Dec 31, 20218.19M-2.75M-25.10%
Dec 31, 202010.94M6.96M175.03%
Dec 31, 20193.98M1.59M66.40%
Dec 31, 20182.39M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aytu BioPharma 93.76M
Flora Growth 74.78M
Cue Health 70.94M
Psychemedics 21.60M
BIMI International Medical 5.85M
PAVmed 3.02M
Mainz Biomed B.V. 895.48K
Traws Pharma 226.00K
Revenue Rankings